Compliments from blog readers
Betsy and I have received many complimentary notes from blog readers in recognition of our efforts in this blog. For your comments, we are most appreciative.
So often we have learned of patients who have relapsed lymphoma and who have been advised to receive serial chemotherapy treatments or maintenance Rituxan infusions or to undergo transplantation. Sadly, so very often these patients have not been told by oncologists of the efficacy and the easy-tolerability of radioimmunotherapy (RIT).
In part related to our efforts, many patients have avoided the recurrent infusions of CHOP chemotherapy and Rituxan; rather, they have received RIT with wonderful results.
Our immense satisfaction is in helping fellow lymphoma patients regain their health and maintain vigorous function and, at the same time, avoid toxic and protracted treatments.
Our message is simple: the lymphoma patient must take the initiative and have a consultation with a physician who is an expert in RIT, a radiation oncologist or nuclear medicine physician, in order to learn whether this treatment modality is appropriate for him or her.
Mort